Teva's generic version of AstraZeneca's Nexium gets FDA nod
Add BT as a preferred sourceNew York
THE US Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.
The approval comes as generic drugmakers scramble to get their versions to the market and AstraZeneca is taken to court over so-called "pay-for-delay" settlements to delay the launch of generics to protect its drug's exclusivity.
TRENDING NOW
Nearly half of Apac’s wealthy expect market crash or correction, plan to rotate to cash: study
Singapore’s CapitaLand sheds 10% of China staff amid downturn
Jumbo Seafood to close flagship East Coast Seafood Centre outlet on Sep 30
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
